Shanghai MicroPort Gets China Approval For Targeted Drug-eluting Stent
This article was originally published in PharmAsia News
Executive Summary
Shanghai MicroPort Medical announced that its Firehawk Rapamycin-eluting coronary stent was approved by China FDA.